Ironwood pharmaceuticals news
WebApr 15, 2024 · The stock, however, is off -83.80% from where it was a year ago. Additionally, there is a loss of -2.06% for Cumberland Pharmaceuticals Inc. (CPIX) in last trading while the stock has seen an overall depriciation of -26.73%% over the past year. The PE ratio stands at 11.39 for Ironwood Pharmaceuticals Inc., compared to 70.08 for AstraZeneca PLC. WebApr 14, 2024 · Ironwood Pharmaceuticals has a one year low of $9.73 and a one year high of $12.66. Ironwood Pharmaceuticals ( NASDAQ:IRWD – Get Rating) last announced its …
Ironwood pharmaceuticals news
Did you know?
WebMar 9, 2024 · Ironwood Pharmaceuticals News More News Seeking Alpha 22d Ironwood Pharmaceuticals Non-GAAP EPS of $0.27 beats by $0.01, revenue of $107.2M misses by $1.02M, guidance in-line WebApr 14, 2024 · Ironwood Pharmaceuticals had a net margin of 42.64% and a return on equity of 30.49%. The business had revenue of $107.20 million during the quarter, compared to analyst estimates of $108.23...
WebJan 9, 2024 · Ironwood Pharmaceuticals Provides Update on FY 2024 Financial Guidance and Announces FY 2024 Financial Guidance – sNDA submitted to U.S. FDA in December … WebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI …
WebSep 6, 2024 · BOSTON, Mass., September 06, 2024 -- ( BUSINESS WIRE )-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), today announced positive topline data from a Phase III clinical trial evaluating LINZESS... WebApr 10, 2024 · Ironwood Pharmaceuticals, Inc is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics...
WebJan 29, 2024 · Astellas Pharma Inc. (TSE:4503) and Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) announced today top-line results indicating that the Phase III clinical trial of linaclotide conducted in Japan in adults with chronic constipation (CC) met its primary endpoint. Linaclotide is approved in Japan as the first prescription treatment for adults …
WebIronwood Pharmaceuticals 27,221 followers 1d Edited Our Director of Research Quality Assurance, Cheryl McCarthy, CQA, CBA, RQAP-GCP will be giving the President’s speech as well as chairing the... ray whelans carlowWebJan 9, 2024 · Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) shares are trading lower by 10.00% to $11.30 Monday afternoon after the company cut its FY22 sales guidance below … simply southern blessed mimi shirtWeb1 day ago · BOSTON-- (BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its second quarter 2024 results and recent business performance. “We made progre... 8 months ago - Business Wire Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call simply southern bistro and grillWeb1 day ago · Ironwood Pharmaceuticals Reports Strong Third Quarter 2024 Results; Maintains Full Year 2024 Financial Guidance. BOSTON--(BUSINESS WIRE)--Ironwood … simply southern blanket ponchoWebApr 12, 2024 · Shares of IRWD opened at $10.77 on Wednesday. Ironwood Pharmaceuticals, Inc. has a 1 year low of $9.73 and a 1 year high of $12.66. The company has a market cap of $1.66 billion, a price-to ... simply southern blanket hoodieWebSep 6, 2024 · BOSTON, Mass., September 06, 2024--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), today announced positive topline data from a Phase III clinical trial … ray whelan skipWebApr 11, 2024 · Ironwood Pharmaceuticals Inc. on Tuesday said it has eliminated the role of chief operating officer in a streamlining of the healthcare company's executive leadership team. As a result, the Boston ... ray whelan waste disposal